Matinas Biopharma Holdings, Inc. (MTNB) vs Oragenics, Inc. (OGEN)
Matinas Biopharma Holdings, Inc. and Oragenics, Inc. are both Biotechnology companies. Matinas Biopharma Holdings, Inc. and Oragenics, Inc. are of similar size ($2.4M and $2.3M). Matinas Biopharma Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; Oragenics, Inc. trades at 0.4×. Matinas Biopharma Holdings, Inc. grew revenue faster over the last twelve months: 2,139.4% against −75.1%. Across the 15 metrics below, Oragenics, Inc. leads on 8 and Matinas Biopharma Holdings, Inc. on 7.
Valuation
Profitability
| Metric | MTNB | OGEN | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 19.89% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (154.28%) | (1,307.07%) | (57.72%) |
| Return on assets | (98.53%) | (264.23%) | (49.22%) |
| Return on invested capital | (419.27%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack